Antitumour Activity of Purified Arabinogalactan-peptidoglycan Complex of the Cell Wall Skeleton of Rhodococcus lentifragmentus

References

1. Adam A., Ciorbaru R., Ellouz F., Petit J.-F., Lederer E. 1974; Adjuvant activity of monomeric bacterial cell wall peptidoglycans. Biochemical and Biophysical Research Communications 56:561–567
   [Google Scholar]
2. Adam A., Devys M., Souvannavong V., Lefrancier P., Choay J., Lederer E. 1976; Correlation of structure and adjuvant activity of N-acetylmuramyl-l-alanyl-d-isoglutamine (MDP), its derivatives and analogues. Anti-adjuvant and competition properties of stereoisomers. Biochemical and Biophysical Research Communications 72:339–346
   [Google Scholar]
3. Azuma I., Taniyama T., Hirao F., Yamamura Y. 1974; Antitumour activity of cell-wall skeletons and peptidoglycolipids of mycobacteria and related microorganisms in mice and rabbits. Gann 65:493–505
   [Google Scholar]
4. Azuma I., Kanetsuna F., Taniyama T., Hori M., Tanaka Y. 1975; Adjuvant activity of mycobacterial fractions. I. Purification and in vivo adjuvant activity of cell wall skeletons of Mycobacterium bovis BCG, Nocardia asteroides 131 and Corynebacterium diphtheriae PW8. Biken Journal 18:1–13
   [Google Scholar]
5. Azuma I., Taniyama T., Yamawaki M., Sugimura K., Yamamura Y. 1976; Adjuvant and antitumor activities of Nocardia cell-wall skeletons. Gann 67:733–736
   [Google Scholar]
6. Azuma I., Okumura H., Saiki I., Tanio Y., Kiso M., Hasegawa A., Yamamura Y. 1983; Adjuvant activity of carbohydrate analogs of N- acetylmuramyl-alanyl-d-isoglutamine on the induction of delayed-type hypersensitivity to azobenzene-arsenate-N-acetyl-l-tyrosine in guinea pigs. Infection and Immunity 41:462–469
   [Google Scholar]
7. Barksdale L., Kim K. S. 1977; Mycobacterium. Bacteriological Reviews 41:217–372
   [Google Scholar]
8. Elouz F., Adam A., Ciorbaru R., Lederer E. 1974; Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. Biochemical and Biophysical Research Communications 59:1317–1325
   [Google Scholar]
9. Fidler I. J., Sone S., Fogler W. E., Barnes Z. L. 1981; Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide. Proceedings of the National Academy of Sciences of the United States of America 78:1680–1684
   [Google Scholar]
10. Fujioka M., Koda S., Morimoto Y. 1985; Novel glycosidic linkage between arabinogalactan and peptidoglycan in the cell wall skeleton of Nocardia rubra AN-115. Journal of General Microbiology 131:1325–1329
    [Google Scholar]
11. Hrsak I., Tomasic J., Osmak M. 1983; Immunotherapy of B-16 melanoma with peptidoglycan monomer. European Journal of Cancer and Clinical Oncology 19:681–686
    [Google Scholar]
12. Kamisango K., Saiki I., Tanio Y., Okumura H., Araki Y., Sekikawa I., Azuma I., Yamamura Y. 1982; Structures and biological activities of peptidoglycans of Listeria monocytogenes and Propionibacterium acnes . Journal of Biochemistry 92:23–33
    [Google Scholar]
13. Koda S., Fujioka M., Shigi M., Nakashima K., Morimoto Y. 1986; Structural analysis of mycolic acids from the cell wall skeleton of Rhodococcus lentifragmentus AN-115. Journal of General Microbiology 132:1547–1551
    [Google Scholar]
14. Kotani S., Watanabe Y., Kinoshita F., Shimono T., Morosaki I., Shiba T., Kusumoto S., Tarumi Y., Ikenaka K. 1975; Immunoadjuvant activities of synthetic A-acetyl-muramyl-peptides or amino acids. Biken Journal 18:105–111
    [Google Scholar]
15. Kusumoto S., Inage M., Shiba T. 1978; Synthesis of long chain fatty acid esters of vV-acetylmuramyl-l-alanyl-d-isoglutamine in relation to antitumor activity. Tetrahedron Letters 49:4899–4902
    [Google Scholar]
16. Lederer E. 1971; The mycobacterial cell wall. Pure and Applied Chemistry 25:135–165
    [Google Scholar]
17. Mclaughlin C. A., Schwartzman S. M., Horner B. L., Jones G. H., Moffatt J. G., Nestor J. J. JR Tegg D. 1980; Regression of tumors in guinea pigs after treatment with synthetic muramyl dipeptides and trehalose dimycolate. Science 208:415–416
    [Google Scholar]
18. Michel G., Bordet C. 1976; Cell wall of Nocardia . In The Biology of the Nocardiae, pp 141–159 Goodfellow M., Brownell G. M., Serrano J. A. Edited by London: Academic Press;
    [Google Scholar]
19. Ohara K., Fujitsu T., Sakuma S., Ina K., Senoh H., Mori J., Kikuchi H. 1986; Antigenicity of Nocardia rubra cell wall skeleton (N-CWS). (1) Antigenicity of N-CWS in mice and guinea pigs. Harmacometrics 31:735–744
    [Google Scholar]
20. Saiki I., Kamisango K., Tanio Y., Okumura H., Yamamura Y., Azuma I. 1982; Adjuvant activity of purified peptidoglycan of Listeria monocytogenes in mice and guinea pigs. Infection and Immunity 38:58–66
    [Google Scholar]
21. Tsukamura M. 1985; Priority of Rhodococcus lentifragmentus (Kruse 1869; Tsukamura et al. 1975) Tsukamura 1978 comb. nov. over Rhodococcus ruber (Kruse 1896) Goodfellow and Alderson 1980. International Journal of Systematic Bacteriology 35:124–125
    [Google Scholar]
22. Yamawaki M., Azuma I., Saiki I., Uemiya M., Aoki O., Ennu K., Yamamura Y. 1978; Antitumor activity of squalene-treated cell wall skeleton of Nocardia rubra in mice. Gann 69:619–626
    [Google Scholar]
23. Yarconi E., Lederer E., Rapp H. J. 1981; Immunotherapy of experimental cancer with a mixture of synthetic muramyl dipeptide and trehalose dimycolate. Infection and Immunity 32:273–276
    [Google Scholar]